BACKGROUND: The pathogenesis of psoriasis vulgaris involves changes in DNA molecules, genomic instability, telomere attrition, and epigenetic alterations among them. These changes are also considered important mechanisms of aging in cells and tissues. OBJECTIVE: This study dealt with oxidation damage, telomere length and methylation status in DNA originating from peripheral blood of 41 psoriatic patients and 30 healthy controls. METHODS: Oxidative damage of serum DNA/RNA was determined immunochemically. Real-time PCR was used for the analysis of the telomere length. ELISA technique determined levels of 5-methylcytosine in blood cells' DNA. RESULTS: Oxidative damage of serum DNA/RNA was higher in patients than in controls (median, 3758 vs. 2286pg/mL, p<0.001). A higher length of telomeres per chromosome was found in patients whole-cell DNA than in controls (3.57 vs. 3.04 kilobases, p=0.011). A negative correlation of the length of telomeres with an age of the control subjects was revealed (Spearman's rho=-0.420, p=0.028). Insignificantly different levels of 5-methylcytosine in patients and controls were observed (33.20 vs. 23.35%, p=0.234). No influences of sex, smoking, BMI, PASI score, and metabolic syndrome on the methylation status were found. STUDY LIMITATIONS: i) A relatively small number of the participants, particularly for reliable subgroup analyses, ii) the Caucasian origin of the participants possibly influencing the results of the parameters determined, and iii) Telomerase activity was not directly measured in serum or blood cells. CONCLUSION: The study demonstrated increased levels of oxidized DNA/RNA molecules in the serum of patients with exacerbated psoriasis vulgaris. The results were minimally influenced by sex, the presence of metabolic syndrome, or cigarette smoking. In the psoriatic blood cells' DNA, the authors observed longer telomeres compared to healthy controls, particularly in females. Insignificantly higher global DNA methylation in psoriasis cases compared to the controls indicated marginal clinical importance of this epigenetic test performed in the blood cells' DNA.

Clinic of Dermatology and Venereology University Hospital Hradec Kralove Czech Republic

Department of Medical Biophysics Charles University Faculty of Medicine Hradec Kralove Czech Republic

Institute of Clinical Biochemistry and Diagnostics University Hospital Hradec Kralove and Faculty of Medicine Hradec Kralove Charles University Czech Republic

Institute of Clinical Biochemistry and Diagnostics University Hospital Hradec Kralove and Faculty of Medicine Hradec Kralove Charles University Czech Republic; Department of Biochemical Sciences Faculty of Pharmacy Hradec Kralove Charles University Czech Republic

Institute of Clinical Immunology and Allergology Charles University Faculty of Medicine Hradec Kralove Czech Republic

Institute of Preventive Medicine Charles University Faculty of Medicine Hradec Kralove Czech Republic

Zobrazit více v PubMed

Eding C.B., Enerbäck C. Involved and uninvolved psoriatic keratinocytes display a resistance to apoptosis that may contribute to epidermal thickness. Acta Derm Venereol. 2017;97:788–796. PubMed

Owczarczyk-Saczonek A., Czerwinska J., Placek W. The role of regulatory T cells and anti-inflammatory cytokines in psoriasis. Acta Dermatovenerol Alp Pannonica Adriat. 2018;27:17–23. PubMed

Borsky P., Chmelarova M., Fiala Z., Hamakova K., Palicka V., Krejsek J., et al. Aging in psoriasis vulgaris: female patients are epigenetically older than healthy controls. Immun Ageing. 2021;18:10. PubMed PMC

Moskalev A.A., Shaposhnikov M.V., Plyusnina E.N., Zhavoronkov A., Budovsky A., Yanai H., et al. The role of DNA damagee and repair in aging through the prism of Koch-like criteria. Ageing Res Rev. 2013;12:661–684. PubMed

Lopez-Otin C., Blasco M.A., Partridge L., Serrano M., Kroemer G. The hallmarks of aging. Cell. 2013;153:1194–1217. PubMed PMC

Basavaraj K.H., Vasu Devaraju P., Rao K.S. Studies on serum 8-hydroxy guanosine (8-OHdG) as reliable biomarker for psoriasis. J Eur Acad Dermatol Venereol. 2013;27:655–657. PubMed

Borska L., Kremlacek J., Andrys C., Krejsek J., Hamakova K., Borsky P., et al. Systemic inflammation, oxidative damage to nucleic acids, and metabolic syndrome in the pathogenesis of psoriasis. Int J Mol Sci. 2017;18:2238. PubMed PMC

Borska L., Andrys C., Krejsek J., Palicka V., Vorisek V., Hamakova K., et al. Influence of dermal exposure to ultraviolet radiation and coal tar (polycyclic aromatic hydrocarbons) on the skin aging process. J Dermatol Sci. 2016;81:192–202. PubMed

Kordinas V., Ioannidis A., Chatzipanagiotou S. The telomere/telomerase system in chronic inflammatory diseases. Cause or effect? Genes (Basel). 2016;7:60. PubMed PMC

Robertson J.D., Gale R.E., Wynn R.F., Dougal M., Linch D.C., Testa N.G., et al. Dynamics of telomere shortening in neutrophils and T lymphocytes during ageing and the relationship to skewed X chromosome inactivation patterns. Br J Haematol. 2000;109:272–279. PubMed

Svenson U., Nordfjäll K., Baird D., Roger L., Osterman P., Hellenius M.L., et al. Blood cell telomere length is a dynamic feature. PLoS One. 2011;6 PubMed PMC

Tamayo M., Mosquera A., Rego J.I., Fernández-Sueiro J.L., Blanco F.J., Fernández J.L. Differing patterns of peripheral blood leukocyte telomere length in rheumatologic diseases. Mutat Res. 2010;683:68–73. PubMed

Wu K., Higashi N., Hansen E.R., Lund M., Bang K., Thestrup-Pedersen K. Telomerase activity is increased, and telomere length shortened in T cells from blood of patients with atopic dermatitis and psoriasis. J Immunol. 2000;165:4742–4747. PubMed

Schonland S.O., Lopez C., Widmann T., Zimmer J., Bryl E., Goronzy J.J., et al. Premature telomeric loss in rheumatoid arthritis is genetically determined and involves both myeloid and lymphoid cell lineages. Proc Natl Acad Sci USA. 2003;100:13471–13476. PubMed PMC

Yudoh K., Nguyen T., Nakamura H., Hongo-Masuko K., Kato T., Nishioka K. Potential involvement of oxidative stress in cartilage senescence and development of osteoarthritis: oxidative stress induces chondrocyte telomere instability and downregulation of chondrocyte function. Arthritis Res Ther. 2005;7:R380–91. PubMed PMC

Wu C.H., Hsieh S.C., Li K.J., Lu M.C., Yu C.L. Premature telomere shortening in polymorphonuclear neutrophils from patients with systemic lupus erythematosus is related to the lupus disease activity. Lupus. 2007;16:265–272. PubMed

Chandra A., Ray A., Senapati S., Chatterjee R. Genetic and epigenetic basis of psoriasis pathogenesis. Mol Immunol. 2015;64:313–323. PubMed

Tsoi L.C., Stuart P.E., Tian C., Gudjonsson J.E., Das S., Zawistowski M., et al. Large scale meta-analysis characterizes genetic architecture for common psoriasis associated variants. Nat Commun. 2017;8:15382. PubMed PMC

Zhang P., Su Y., Chen H., Zhao M., Lu Q. Abnormal DNA methylation in skin lesions and PBMCs of patients with psoriasis vulgaris. J Dermatol Sci. 2010;60:40–42. PubMed

Whyte J.M., Ellis J.J., Brown M.A., Kenna T.J. Best practices in DNA methylation: lessons from inflammatory bowel disease, psoriasis and ankylosing spondylitis. Arthritis Res Ther. 2019;21:133. PubMed PMC

Borsky P., Chmelarova M., Fiala Z., Palicka V., Beranek M., Kremlacek J., et al. Variation of selected genotoxic and epigenetic markers due to therapeutic exposure to PAHs and ultraviolet radiation. Bratisl Lek Listy. 2020;121:558–564. PubMed

Salihbegovic E.M., Hadzigrahic N., Cickusic A.J. Psoriasis and metabolic syndrome. Med Arch. 2015;69:85–87. PubMed PMC

Milcic D., Jankovic S., Vesic S., Milinkovic M., Marinkovic J., Cirkovic A., et al. Prevalence of metabolic syndrome in patients with psoriasis: A hospital-based cross-sectional study. An Bras Dermatol. 2017;92:46–51. PubMed PMC

Barygina V., Becatti M., Lotti T., Taddei N., Fiorillo C. Low dose cytokines reduce oxidative stress in primary lesional fibroblasts obtained from psoriatic patients. J Dermatol Sci. 2016;83:242–244. PubMed

Holmannova D., Borska L., Andrys C., Borsky P., Kremlacek J., Hamakova K., et al. The impact of psoriasis and metabolic syndrome on the systemic inflammation and oxidative damage to nucleic acids. J Immunol Res. 2020 PubMed PMC

Cawton R.M., Smith K.R., O’Brien E., Silvatchenko A., Kerber R.A. Association between telomere length in blood and mortality in people aged 60 years or older. Lancet. 2003;361:393–395. PubMed

Njajou O.T., Cawthon R.M., Damcott C.M., Wu S.H., Ott S., Garant M.J., et al. Telomere length is paternally inherited and is associated with parental lifespan. Proc Natl Acad Sci USA. 2007;104:12135–12139. PubMed PMC

Tosevska A., Franzke B., Hofmann M., Vierheilig I., Schober-Halper B., Oesen S., et al. Circulating cell-free DNA, telomere length and bilirubin in the Vienna Active Ageing Study: exploratory analysis of a randomized, controlled trial. Sci Rep. 2016;6:38084. PubMed PMC

Coussens E., Grine L., Bostoen J., Mielants H., Lambert J. Analysis of telomere length as predictive marker in psoriasis for comorbidities. Exp Dermatol. 2016;25:388–390. PubMed

Zhang K., Zhang R., Li X., Yin G., Niu X., Hou R. The mRNA expression and promoter methylation status of the p16 gene in colony-forming cells with high proliferative potential in patients with psoriasis. Clin Exp Dermatol. 2007;32:702–708. PubMed

Fujii H., Shao L., Colmegna I., Goronzy J.J., Weyand C.M. Telomerase insufficiency in rheumatoid arthritis. Proc Natl Acad Sci USA. 2009;106:4360–4365. PubMed PMC

Dehbi A.Z., Radstake T.R., Broen J.C. Accelerated telomere shortening in rheumatic diseases: Cause or consequence? Expert Rev Clin Immunol. 2013;9:1193–1204. PubMed

Liu X., Lin J., Wang L., Zhang Z., Hou S., Yang G. Telomerase activity in peripheral blood mononuclear cells of psoriatic patients correlates with disease severity. Br J Dermatol. 2008;158:637–639. PubMed

Roberson E.D., Liu Y., Ryan C., Joyce C.E., Duan S., Cao L., et al. A subset of methylated CpG sites differentiate psoriatic from normal skin. J Invest Dermatol. 2012;132:583–592. PubMed PMC

Chen M., Chen Z.Q., Cui P.G., Yao X., Li Y.M., Li A.S., et al. The methylation pattern of p16INK4a gene promoter in psoriatic epidermis and its clinical significance. Br J Dermatol. 2008;158:987–993. PubMed

Ngalamika O., Liang G., Zhao M., Yu X., Yang Y., Yin H., et al. Peripheral whole blood FOXP3 TSDR methylation: a potential marker in severity assessment of autoimmune diseases and chronic infections. Immunol Invest. 2015;44:126–136. PubMed

Pollock R.A., Abji F., Gladman D.D. Epigenetics of psoriatic disease: A systematic review and critical appraisal. J Autoimmun. 2017;78:29–38. PubMed

Mervis J.S., McGee J.S. DNA methylation and inflammatory skin diseases. Arch Dermatol Res. 2020;312:461–466. PubMed

Rosenberger S., Thorey I.S., Werner S., Boukamp P. A novel regulator of telomerase. S100A8 mediates differentiation-dependent and calcium-induced inhibition of telomerase activity in the human epidermal keratinocyte line HaCaT. J Biol Chem. 2007;282:6126–6135. PubMed